Company: BLTE
Filing Date: 2025-12-02
Form Type: 424B5
Source: 0001104659-25-117702
Chunk: 61

Company: BELITE BIO, INC
Filing Date: 2025-12-02
Form: 424B5
Chunk 61
---
 the ADSs, the offering price and other selling terms may from time to time be varied by the representatives. We have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus supplement, to purchase up to 340,909 additional ADSs at the public offering price listed on the cover page of this prospectus supplement, less underwriting discounts and commissions. To the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional ADSs as the number listed next to the underwriter’s name in the preceding table bears to the total number of shares ADSs listed next to the names of all underwriters in the preceding table. The following table shows the per ADS and total public offering price, underwriting discounts and commissions, and proceeds before expenses to us. These amounts are shown assuming both no exercise and full exercise of the underwriters’ option to purchase up to an additional 340,909 ADSs.

| ​                                                       
 ​                                                       | ​ 
 ​ | ​ 
 ​ | ​       
 Per ADS | ​ |      ​ | ​ | ​ 
 ​ | ​ 
 ​ | Total       
 No Exercise |   |                |   | ​ | ​ | Full Exercise |   |                |   | ​ 
 ​ |
|:--------------------------------------------------------|:--|:--|:--------|:--|-------:|:--|:--|:--|:------------|:--|---------------:|:--|:--|:--|:--------------|:--|---------------:|:--|:--|
| Public offering price                                   | ​ | ​ | ​       | $ | 154.00 | ​ | ​ | ​ | ​           | $ | 349,999,958.00 | ​ | ​ | ​ | ​             | $ | 402,499,944.00 | ​ | ​ |
| Underwriting discounts and commissions to be paid by us | ​ | ​ | ​       | $ |   9.24 | ​ | ​ | ​ | ​           | $ |  20,999,997.48 | ​ | ​ | ​ | ​             | $ |  24,149,996.64 | ​ | ​ |
| Proceeds, before expenses, to us                        | ​ | ​ | ​       | $ | 144.76 | ​ | ​ | ​ | ​           | $ | 328,999,960.52